$390 Million is the total value of ARCH Venture Management, LLC's 8 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 20.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DNLI | DENALI THERAPEUTICS, INC. | $102,027,910 | -9.4% | 3,668,749 | 0.0% | 26.13% | +79.0% | |
| KRTX | Sell | KARUNA THERAPEUTICS, INC. | $100,779,348 | -65.9% | 512,872 | -60.9% | 25.81% | -32.6% |
| EQRX, INC. | $89,385,023 | -50.3% | 36,335,375 | 0.0% | 22.90% | -1.8% | ||
| ERASCA, INC. | $47,649,438 | -44.7% | 11,055,554 | 0.0% | 12.20% | +9.2% | ||
| VERV | VERVE THERAPEUTICS, INC. | $38,870,454 | -43.7% | 2,008,809 | 0.0% | 9.96% | +11.3% | |
| OMIC | SINGULAR GENOMICS SYSTEMS, INC. | $7,635,841 | -19.6% | 3,798,926 | 0.0% | 1.96% | +58.9% | |
| Sell | UNITY BIOTECHNOLOGY, INC. | $2,753,199 | -30.6% | 1,004,817 | -90.0% | 0.70% | +36.9% | |
| MTCR | METACRINE, INC. | $1,317,051 | -7.6% | 2,940,503 | 0.0% | 0.34% | +82.2% | |
| RUBY | Exit | RUBIUS THERAPEUTICS, INC. | $0 | – | -349,908 | -100.0% | -0.02% | – |
| REVH | Exit | REVOLUTION HEALTHCARE ACQUISITION CORP. | $0 | – | -1,357,237 | -100.0% | -1.73% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| RUBIUS THERAPEUTICS, INC. | 12 | Q3 2022 | 65.5% |
| EQRX, INC. | 8 | Q3 2023 | 52.4% |
| ERASCA, INC. | 8 | Q3 2023 | 18.8% |
| VERVE THERAPEUTICS, INC. | 8 | Q3 2023 | 23.3% |
| CHIASMA INC | 8 | Q3 2020 | 25.7% |
| SINGULAR GENOMICS SYSTEMS, INC. | 8 | Q3 2023 | 4.6% |
| KURA ONCOLOGY INC | 7 | Q2 2020 | 27.6% |
| KARUNA THERAPEUTICS, INC. | 6 | Q1 2023 | 52.8% |
| DENALI THERAPEUTICS, INC. | 6 | Q3 2023 | 28.6% |
| SYROS PHARMACEUTICALS INC | 5 | Q3 2020 | 43.8% |
View ARCH Venture Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-15 |
| 13F-HR/A | 2022-05-27 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
View ARCH Venture Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.